Viatris agrees to acquire Pasira Bioscience for $1.65 billion
VTRS Viatris Inc
$17.44 -0.29%
View chart & analysis → 
- 1Viatris has agreed to acquire Pasira Bioscience for a cash consideration of $1.65 billion.
- 2Viatris will launch a tender offer at an acquisition price of $36.50 per share for Pasira Bioscience.
- 3The boards of both companies have unanimously approved the transaction.
So what's the key point?
Viatris has decided to buy Pasira Bioscience for $1.65 billion. The company plans to acquire the business by purchasing shares at $36.50 per share.
Source The Wall Street Journal +7 · View original ↗
Today's 5 AI picks, all freeNothing hidden: past picks and how they did against the S&P 500.